Table 1.
Study variables assessed in the non-diabetic Chilean women (n = 57) of this research.
| Mean ± Standard Deviation | |
|---|---|
| Age (years) | 27.4 ± 6.9 |
| Weight (kg) | 60.1 ± 9.3 |
| Height (m) | 1.59 ± 0.07 |
| BMI (kg/m2) | 23.8 ± 3.5 |
| HOMA-S index | 77.9 ± 44.0 |
| OGTT-based Matsuda-ISICOMP index | 5.7 ± 3.0 |
| OGTT-based insulinogenic index | 0.43 ± 0.22 |
| OGTT-based C-peptidogenic index | 0.31 ± 1.34 |
| OGTT-based Disposition Index (ODI using C-peptide) | 0.20 ± 0.12 |
| OGTT-based Disposition Index (ODI using insulin) | 3.06 ± 1.14 |
| IVGTT-based CSi Index | 6.46 ± 4.01 |
| IVGTT-based AIR Index | 59.7 ± 33.62 |
| IVGTT-based Disposition Index (DI) | 337.3 ± 202.4 |
| % methylation (position -922) (Illumina 450K array) | 61.5 ± 3 |
| % methylation (position -841) (Illumina 450K array) | 71.7 ± 3 |
| % methylation (position -816) (Pyrosequencing) | 82 ± 3.1 |
| % methylation (position -783) (Pyrosequencing) | 68.7 ± 3.6 |
| % methylation (position -652) (Pyrosequencing) | 31.5 ± 5.6 |
| % methylation (position -617) (Pyrosequencing) | 43.3 ± 6.6 |
| % methylation (position -521) (Pyrosequencing) | 24.8 ± 4.3 |
| % methylation (position -515) (Pyrosequencing) | 53.1 ± 7.0 |
| % methylation (position -383) (Illumina 450K array) | 14.7 ± 0.02 |
| % methylation (position -136) (Illumina 450K array) | 12.4 ± 0.02 |
AIR: Acute insulin release, BMI: Body mass index, CSi: Calculated sensitivity index, DI: Disposition Index, HOMA-S: Homeostasis model assessment-insulin sensitivity, IVGTT: Intravenous glucose tolerance test, Matsuda-ISICOMP index: Matsuda composite index, ODI: Oral disposition index, OGTT: Oral glucose tolerance test.